Lillian Lamb

Lillian Lamb supports the Food and Drug Administration’s Office of Acquisition and Grant Services in executing mission-critical procurement activities that sustain the agency’s regulatory science infrastructure. She manages a portfolio of professional and scientific services contracts essential to advancing the FDA’s public health mandate, including laboratory operations, analytical instrumentation support, and biotechnological research services. Her work ensures the timely acquisition of high-precision technical capabilities required for drug safety evaluations, medical device testing, and biological product oversight. Lamb’s contracting efforts are strategically aligned with the FDA’s focus on maintaining scientific integrity and operational readiness across its national laboratory network. She maintains consistent working relationships with specialized scientific service providers, including Tranquil Clinical and Research Consulting Services LLC, Toxicologic Pathology Associates Inc., and Progenics Pharmaceuticals Inc., reflecting a preference for niche vendors with deep expertise in preclinical research, toxicology, and pharmaceutical development. These partnerships are typically non-competitive or limited-source, grounded in technical specificity and domain proficiency rather than broad commercial capability. Her procurement approach emphasizes quality, regulatory compliance, and continuity of scientific services over volume or cost-driven outcomes. Lamb’s contracting activity is exclusively non-set-aside, with 100% of awards issued under full and open competition. This reflects a strategic prioritization of technical merit and specialized capability over socioeconomic preferences, indicating a procurement philosophy centered on mission-critical performance rather than socioeconomic targets. While small business participation is not formally incentivized in her portfolio, vendors are selected based on demonstrated expertise in highly regulated scientific environments. Her primary procurement focus lies in NAICS 541990 (All Other Professional, Scientific, and Technical Services), complemented by significant activity in NAICS 541714 (Biotechnology R&D) and 541715 (Physical and Life Sciences R&D). She routinely acquires services involving clinical trial support, analytical method validation, toxicological assessment, and laboratory automation—domains requiring deep regulatory knowledge and adherence to Good Laboratory Practices (GLP) and Good Clinical Practices (GCP).